Board Meeting20 Oct 2026, 12:14 pm
Orchid Pharma Eyes Up to ₹600 Cr Fundraising
AI Summary
Orchid Pharma Ltd announced that its Board of Directors has passed an enabling resolution to explore fundraising opportunities of up to ₹600 Crores (Rupees Six Hundred Crore Only). The funds can be raised through various modes including equity shares, convertible debentures, qualified institutions placement, private placement, public issue of equity shares and/or debt securities, or preferential issue. The decision is subject to necessary statutory, regulatory, and member approvals. The board meeting commenced on October 20, 2026, at 11:00 AM IST and concluded at 11:50 AM IST.
Key Highlights
- Board approved exploring fundraising up to ₹600 Crores.
- Funds can be raised via equity, convertibles, QIP, or preferential issue.
- Subject to statutory, regulatory, and member approvals.
- Decision made during the Board Meeting held on October 20, 2026.
Price Impact
More from ORCHPHARMA